delivery of chemically stabilized rnai molecules to the central nervous system
Published 1 year ago • 1.8K plays • Length 59:22Download video MP4
Download video MP3
Similar videos
-
59:20
anastasia khvorova: rnai-based therapeutics: 2018 outlook
-
1:01:51
pitfalls and progress in the development of immune stimulatory nucleic acids
-
1:12:31
designing sirnas for improving their therapeutic applications
-
30:13
lipid nanoparticle delivery technology for sirna and mrna therapeutics
-
58:52
delivery of macromolecular therapeutics: tackling a billion year old barrier
-
33:21
chemistry of therapeutic oligonucleotides: a brief overview
-
1:10:26
rna targeting technology – chemistry and delivery | richard geary
-
1:12:47
circular rna immunity
-
19:33
oligo meeting 2017 - rnai drug discovery
-
22:36
antisense oligonucleotides part 1
-
31:01
addressing delivery hurdles in the translation of oligonucleotide therapeutics
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
1:42
oligonucleotide-based therapeutics
-
2:14
what are oligonucleotide therapeutics? - therapeutic oligonucleotides development
-
58:19
karyn o’neil: muscle targeted sirna conjugates for pompe disease
-
1:05
how does it work? | antisense oligonucleotide therapy
-
57:50
meet your 2022 ots trainee reps
-
1:02:39
mano manoharan: the world of galnac conjugates in nucleic acid therapeutics
-
3:34
rnai therapeutics - how this new class of medicines works
-
1:02:44
opening & keynote